BluMaiden Biosciences is a platform company that has developed transformational Artificial Intelligence that identifies biomarkers and therapeutics from within the human microbiome. The Company is currently engaged in a number of clinical trials and collaborations with clinical institutions and Biotech | Pharma companies to scale up its proprietary metagenomic database. Run by an accomplished founding team, and backed by a panel of experienced and global investors and scientific advisors, BluMaiden is building a sustainable business with enduring competitive advantage.